In biopsies from breast cancer patients, the local CCL5 protein expression was observed to be elevated in invasive breast carcinomas compared to in situ ductal tumors or benign lesions [43,44], and CCL5 expression was immunolocalized in biopsies specifically representing the tumor–stroma border [23]. The gene discussed is CCL5; the disease is breast carcinoma.